Biovectra is defunct.
Acquired by Agilent, Sep 2024; Mallinckrodt sold unit to Private Equity, Sep 2019, $135M + $40M note + $75M contingents
----------------------------------------
If you believe any of this information is incorrect, please
let us know.
If you would like in depth information on the active companies in our directory, please check out our
data purchase page to learn more about the data fields we have and how the purchasing process works.
We are always happy to answer any questions so feel free to contact us through the
contact form.